Innoviva (INVA) vs Kailera Therapeutics (KLRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Innoviva is the larger company by market cap ($1.53 billion vs $1.51 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INVA | KLRA |
|---|---|---|
| Share price | $21.21 | $11.61 |
| Market cap | $1.53B | $1.51B |
| 1-day change | +1.63% | +16.10% |
| YTD return | +4.40% | — |
| 1-year return | +20.15% | — |
| 5-year return | +25.65% | — |
| P/E ratio (TTM) | 4.96 | — |
| Forward P/E | 9.60 | — |
| EPS (TTM) | $4.28 | $-4.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $411.33M | — |
| Revenue growth (YoY) | +14.67% | — |
| Net income (latest FY) | $271.17M | — |
| Gross margin | 74.80% | — |
| Operating margin | 39.81% | — |
| Net margin | 65.92% | — |
| 52-week high | $25.15 | $28.23 |
| 52-week low | $16.52 | $9.76 |
| Distance from 52-week high | -15.67% | -58.87% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +65.02% | +265.20% |
| Average volume | 819.03K | 861.01K |
| Shares outstanding | 72.25M | 129.64M |
| Employees | 159 | 145 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Innoviva
INVA stock →Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 159 employees
About Kailera Therapeutics
KLRA stock →Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
INVA vs KLRA FAQ
Which is bigger, Innoviva or Kailera Therapeutics?
Innoviva (INVA) is larger, with a market capitalization of $1.53B compared with $1.51B for Kailera Therapeutics (KLRA).
Are Innoviva and Kailera Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.